Where I see patients (1)
My reviews
Selected research
-
Patterns of disease-modifying therapy utilization before, during, and after pregnancy and postpartum relapses in women with multiple sclerosis.
Multiple sclerosis and related disorders
-
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
Nature communications
-
Clinical outcomes after use of checkpoint inhibitor immunotherapies in people with multiple sclerosis.
Multiple sclerosis journal - experimental, translational and clinical
Clinical trials
VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)
The primary outcome will be disability worsening in one of the Multiple Sclerosis Functional Composite components at 24 months. Worsening is defined as 20% worsening in Timed 25 foot walking speed (T25FW), 20% worsening in the 9 h...
Recruiting
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
The primary objective is to evaluate the efficacy of BZA relative to placebo for increasing MWF on MRI within normal appearing white matter of the corpus callosum, between baseline and 90 days in a double-blinded trial (1st 90 day...
Recruiting
4.9